Why it was recalled
Presence of Particulate Matter: Hair was found in product
Product description
Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07
Lot numbers, UPCs & expiration codes
Lot #: 6134349, 6134620 Exp. Date 11/2026
Where it was sold
Nationwide within in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0725-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Jul 16, 2026
- FDA report date
- Jul 29, 2026
- Quantity
- 59,425 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Fresenius Kabi USA, LLC
Original FDA data
Every field from FDA enforcement report D-0725-2026, exactly as published.
Show all FDA fields
- City
- Lake Zurich
- State
- IL
- Status
- Ongoing
- Country
- United States
- Event ID
- 99449
- Address
- 3 Corporate Dr
- Code information
- Lot #: 6134349, 6134620 Exp. Date 11/2026
- Postal code
- 60047-8930
- Report date
- Jul 29, 2026
- Product type
- Drugs
- Recall number
- D-0725-2026
- Classification
- Class II
- Recalling firm
- Fresenius Kabi USA, LLC
- Product quantity
- 59,425 vials
- Reason for recall
- Presence of Particulate Matter: Hair was found in product
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07
- Distribution pattern
- Nationwide within in the USA
- Recall initiation date
- Jul 16, 2026
- Initial firm notification
- Letter
- Center classification date
- Jul 23, 2026